Paul Hastings Advises Shareholders on sale of Rowa shares
August 02, 2011
Frankfurt - Paul Hastings LLP, a leading global law firm, announced today that the firm represented the shareholders on the sale of Rowa Automatisierungssysteme GmbH shares to CareFusion Corporation. The shareholders represented were Mr Rudolf Wagner, Mr Markus Willems, Mr Dirk Wingenter and Dr. Christian Klas, the latter three of which will remain as managing directors of the company after closing.
CareFusion plans to continue Rowa’s longstanding focus on retail pharmacy customers, and to accelerate expansion within its hospital customer base. Both companies have complementary positions in their markets: Pyxis® is the US market leader for medication management in hospitals; and Rowa is the European market leader for medication management in retail pharmacies.
The Paul Hastings team was led by Frankfurt-based partner Dr. Peter Smeets, and included Friederike Schroeder, Dr. Christian Mock, Dr. Roland Arlt, Dr. Christoph Boerskens and Dr. Harald Feiler.
With more than 3,500 systems sold, Rowa is the European market leader for automated product handling in pharmacies. The product range includes storage and dispensing systems and accessories, such as fully automatic incoming goods storage. The company, with headquarters in Kelberg, Germany, has more than 300 employees.
CareFusion is a global corporation serving the health care industry with products and services that help measurably improve patient care. The company develops technologies for medication management, including Pyxis® automated dispensing and patient identification systems. Rowa will be integrated into the Pyxis® business unit.
Paul Hastings is a leading global law firm with offices in Asia, Europe, and the United States. We provide innovative legal solutions to financial institutions and Fortune 500 companies. Please visit www.paulhastings.com for more information.